MARSHALL WACE, LLP - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$11,268,183
-95.7%
298,574
-94.8%
0.02%
-95.5%
Q2 2023$260,348,660
+7.3%
5,714,413
-4.4%
0.51%
-1.4%
Q1 2023$242,540,121
+75.7%
5,979,786
+120.8%
0.52%
+65.6%
Q4 2022$138,053,215
+0.4%
2,708,519
+6.1%
0.31%
+3.3%
Q3 2022$137,463,000
+7962.3%
2,552,278
+9514.5%
0.30%
+7425.0%
Q2 2022$1,705,000
-97.6%
26,546
-97.1%
0.00%
-97.1%
Q1 2022$71,853,000
+1081.6%
926,650
+1207.9%
0.14%
+1136.4%
Q4 2021$6,081,000
+171.4%
70,849
+154.5%
0.01%
+10.0%
Q2 2021$2,241,000
-93.5%
27,834
-93.5%
0.01%
-95.5%
Q3 2020$34,386,000
-42.7%
427,578
-38.6%
0.22%
-47.6%
Q2 2020$59,995,000
+177.8%
696,814
+161.9%
0.42%
+94.4%
Q1 2020$21,599,000
-72.4%
266,023
-71.6%
0.22%
-59.9%
Q4 2019$78,373,000
+27.0%
937,252
+32.9%
0.54%
+11.1%
Q3 2019$61,699,000
+144.9%
705,383
+129.3%
0.48%
+134.3%
Q2 2019$25,191,000
+1279.6%
307,584
+1269.4%
0.21%
+2200.0%
Q1 2019$1,826,000
-95.8%
22,462
-96.6%
0.01%
-98.0%
Q4 2018$43,299,000
-13.3%
657,833
+1.6%
0.44%
+108.5%
Q3 2018$49,928,000
+34.6%
647,668
+29.0%
0.21%
-61.8%
Q2 2018$37,082,000
+4741.0%
502,194
+4164.9%
0.56%
+1634.4%
Q1 2018$766,000
-94.9%
11,775
-95.0%
0.03%
-95.0%
Q4 2017$15,164,000
-61.3%
234,599
-73.5%
0.64%
+146.9%
Q4 2016$39,205,000
-51.5%
884,192
-47.9%
0.26%
-55.1%
Q3 2016$80,829,000
+2308.5%
1,698,091
+2188.2%
0.58%
+1953.6%
Q2 2016$3,356,000
-42.0%
74,212
-47.3%
0.03%
-50.0%
Q1 2016$5,785,000
-43.0%
140,838
-2.9%
0.06%
-57.6%
Q2 2015$10,147,000
+207.8%
145,113
+201.5%
0.13%
+207.0%
Q1 2015$3,297,000
-94.7%
48,125
-94.3%
0.04%
-94.7%
Q4 2014$62,017,000
+2318.8%
846,191
+2286.5%
0.82%
+2055.3%
Q2 2014$2,564,000
-90.2%
35,458
-90.0%
0.04%
-92.0%
Q1 2014$26,177,000355,7580.48%
Other shareholders
BAXTER INTL INC shareholders Q3 2021
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders